Page 46 - 《中国药科大学学报》2025年第4期

442 学报 Journal of China Pharmaceutical University 2025, 56(4): 432 − 443 第 56 卷

spectives[J]. Cells, 2019, 8(2): 153. resistance to smoothened antagonists by inhibition of the PI3K
[10] Huang SL, Zhao L, Guo QL, et al. Advances of Hedgehog path- pathway in medulloblastoma[J]. Sci Transl Med, 2010, 2(51):
way in tumor resistance[J]. J China Pharm Univ (中国药科大 51ra70.
学学报), 2016, 47(3): 259-266. [27] Li YH, Luo J, Mosley YC, et al. AMP-activated protein kinase
[11] Quaglio D, Infante P, Di Marcotullio L, et al. Hedgehog signal- directly phosphorylates and destabilizes hedgehog pathway
ing pathway inhibitors: an updated patent review (2015- transcription factor GLI1 in medulloblastoma[J]. Cell Rep,
present)[J]. Expert Opin Ther Pat, 2020, 30(4): 235-250. 2015, 12(4): 599-609.
[12] Xin MH, Ji XY, De La Cruz LK, et al. Strategies to target the [28] Zhang R, Huang SY, Li KK, et al. Dual degradation signals de-
Hedgehog signaling pathway for cancer therapy[J]. Med Res struct GLI1: AMPK inhibits GLI1 through β-TrCP-mediated
Rev, 2018, 38(3): 870-913. proteasome degradation[J]. Oncotarget, 2017, 8(30): 49869-
[13] Dusek CO, Hadden MK. Targeting the GLI family of transcrip- 49881.
tion factors for the development of anti-cancer drugs[J]. Expert [29] Cortes JE, Gutzmer R, Kieran MW, et al. Hedgehog signaling
Opin Drug Discov, 2021, 16(3): 289-302. inhibitors in solid and hematological cancers[J]. Cancer Treat
[14] Pietrobono S, Gagliardi S, Stecca B. Non-canonical hedgehog Rev, 2019, 76: 41-50.
signaling pathway in cancer: activation of GLI transcription fac- [30] Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, et al. Pancre-
tors beyond smoothened[J]. Front Genet, 2019, 10: 556. atic cancer: advances and challenges[J]. Cell, 2023, 186(8):
[15] Kogerman P, Grimm T, Kogerman L, et al. Mammalian sup- 1729-1754.
pressor-of-fused modulates nuclear-cytoplasmic shuttling of [31] Fujikura K, Hosoda W, Felsenstein M, et al. Multiregion whole-
Gli-1[J]. Nat Cell Biol, 1999, 1(5): 312-319. exome sequencing of intraductal papillary mucinous neoplasms
[16] Niewiadomski P, Niedziółka SM, Markiewicz Ł, et al. Gli pro- reveals frequent somatic KLF4 mutations predominantly in low-
teins: regulation in development and cancer[J]. Cells, 2019, grade regions[J]. Gut, 2021, 70(5): 928-939.
8(2): 147. [32] Cancer Genome Atlas Research Network Electronic address:
[17] Shimokawa T, Tostar U, Lauth M, et al. Novel human glioma- andrew_aguirre@dfci harvard edu, Cancer Genome Atlas Re-
associated oncogene 1 (GLI1) splice variants reveal distinct search Network. Integrated genomic characterization of pancre-
mechanisms in the terminal transduction of the hedgehog sig- atic ductal adenocarcinoma[J]. Cancer Cell, 2017, 32(2): 185-
nal[J]. J Biol Chem, 2008, 283(21): 14345-14354. 203. e13.
[18] Galat Y, Gu HG, Perepitchka M, et al. CRISPR editing of the [33] Nolan-Stevaux O, Lau J, Truitt ML, et al. GLI1 is regulated
GLI1 first intron abrogates GLI1 expression and differentially through Smoothened-independent mechanisms in neoplastic
alters lineage commitment[J]. Stem Cells, 2021, 39(5): 564-580. pancreatic ducts and mediates PDAC cell survival and transfor-
[19] Zhou JC, Zhu GD, Huang J, et al. Non-canonical GLI1/2 activa- mation[J]. Genes Dev, 2009, 23(1): 24-36.
tion by PI3K/AKT signaling in renal cell carcinoma: a novel po- [34] Eng C, Yoshino T, Ruíz-García E, et al. Colorectal cancer[J].
tential therapeutic target[J]. Cancer Lett, 2016, 370(2): 313-323. Lancet, 2024, 404(10449): 294-310.
[20] Oro AE, Higgins KM, Hu Z, et al. Basal cell carcinomas in [35] Mazumdar T, DeVecchio J, Agyeman A, et al. The GLI genes
mice overexpressing sonic hedgehog[J]. Science, 1997, as the molecular switch in disrupting Hedgehog signaling in
276(5313): 817-821. colon cancer[J]. Oncotarget, 2011, 2(8): 638-645.
[21] Almomani R, Khanfar M, Bodoor K, et al. Evaluation of [36] Zhao LL, Zhang Y, Zhou JP, et al. Advances in research on
patched-1 protein expression level in low risk and high risk drugs targeting non-small cell lung cancer[J]. J China Pharm
basal cell carcinoma subtypes[J]. Asian Pac J Cancer Prev, Univ (中国药科大学学报), 2014, 45(2): 136-144.
2019, 20(9): 2851-2857. [37] Lei XP, Li Z, Zhong YH, et al. Gli1 promotes epithelial-mes-
[22] Wierbowski BM, Petrov K, Aravena L, et al. Hedgehog path- enchymal transition and metastasis of non-small cell lung carci-
way activation requires coreceptor-catalyzed, lipid-dependent noma by regulating snail transcriptional activity and stability[J].
relay of the sonic hedgehog ligand[J]. Dev Cell, 2020, 55(4): Acta Pharm Sin B, 2022, 12(10): 3877-3890.
450-467. e8. [38] Kasiri S, Shao CL, Chen BZ, et al. GLI1 blockade potentiates
[23] Huang PX, Wierbowski BM, Lian TF, et al. Structural basis for the antitumor activity of PI3K antagonists in lung squamous cell
catalyzed assembly of the Sonic hedgehog-Patched1 signaling carcinoma[J]. Cancer Res, 2017, 77(16): 4448-4459.
complex[J]. Dev Cell, 2022, 57(5): 670-685. e8. [39] Pavletich NP, Pabo CO. Crystal structure of a five-finger GLI-
[24] Kimura H, Stephen D, Joyner A, et al. Gli1 is important for DNA complex: new perspectives on zinc fingers[J]. Science,
medulloblastoma formation in Ptc1+/- mice[J]. Oncogene, 1993, 261(5129): 1701-1707.
2005, 24(25): 4026-4036. [40] Lauth M, Bergström A, Shimokawa T, et al. Inhibition of GLI-
[25] Hartmann W, Digon-Söntgerath B, Koch A, et al. Phos- mediated transcription and tumor cell growth by small-molecule
phatidylinositol 3'-kinase/AKT signaling is activated in medul- antagonists[J]. Proc Natl Acad Sci USA, 2007, 104(20): 8455-
loblastoma cell proliferation and is associated with reduced ex- 8460.
pression of PTEN[J]. Clin Cancer Res, 2006, 12(10): 3019- [41] Calcaterra A, Iovine V, Botta B, et al. Chemical, computational
3027. and functional insights into the chemical stability of the Hedge-
[26] Buonamici S, Williams J, Morrissey M, et al. Interfering with hog pathway inhibitor GANT61[J]. J Enzyme Inhib Med Chem,